Inner Mongolia Furui Medical Science Co., Ltd. (300049) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Inner Mongolia Furui Medical Science Co., Ltd.

Why is Inner Mongolia Furui Medical Science Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 12.56% and Operating profit at 21.74% over the last 5 years

Positive results in Sep 25

OPERATING CASH FLOW(Y) Highest at CNY 314.79 MM
RAW MATERIAL COST(Y) Fallen by -6.77% (YoY)
CASH AND EQV(HY) Highest at CNY 1,450.15 MM

With ROE of 8.88%, it has a very expensive valuation with a 11.03 Price to Book Value

Over the past year, while the stock has generated a return of 75.61%, its profits have fallen by -23.1%

Market Beating Performance

The stock has generated a return of 75.61% in the last 1 year, much higher than market (China Shanghai Composite) returns of 24.70%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Inner Mongolia Furui Medical Science Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Inner Mongolia Furui Medical Science Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Inner Mongolia Furui Medical Science Co., Ltd.

83.79%

0.08

61.99%

China Shanghai Composite

24.7%

1.91

12.95%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.56%

EBIT Growth (5y)

21.74%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.39

Sales to Capital Employed (avg)

0.75

Tax Ratio

27.81%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

21.67%

ROE (avg)

9.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

124

Industry P/E

Price to Book Value

11.03

EV to EBIT

70.30

EV to EBITDA

51.75

EV to Capital Employed

16.55

EV to Sales

13.81

PEG Ratio

Dividend Yield

ROCE (Latest)

23.55%

ROE (Latest)

8.88%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 314.79 MM

RAW MATERIAL COST(Y)

Fallen by -6.77% (YoY

CASH AND EQV(HY)

Highest at CNY 1,450.15 MM

NET SALES(Q)

Highest at CNY 387.63 MM

OPERATING PROFIT(Q)

Highest at CNY 109.29 MM

PRE-TAX PROFIT(Q)

Highest at CNY 109.77 MM

NET PROFIT(Q)

Highest at CNY 59.01 MM

EPS(Q)

Highest at CNY 0.23

-8What is not working for the Company

INTEREST(HY)

At CNY 1.61 MM has Grown at 25.87%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.49 times

Here's what is working for Inner Mongolia Furui Medical Science Co., Ltd.

Net Profit

At CNY 59.01 MM has Grown at 121.54%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 314.79 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 387.63 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 109.29 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 109.77 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 109.77 MM has Grown at 69.12%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 59.01 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.23

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv

Highest at CNY 1,450.15 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -6.77% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Inner Mongolia Furui Medical Science Co., Ltd.

Interest

At CNY 1.61 MM has Grown at 25.87%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio

Lowest at 2.49 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio